Shares of Eyepoint Pharmaceuticals Inc (NASDAQ:EYPT) have received a consensus recommendation of “Buy” from the six ratings firms that are currently covering the stock, MarketBeat reports. Two equities research analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 12 month target price among […]